Preterm Delivery Increases Long-Term Risks of Ischemic Heart Disease in Women Throughout Their Life

Study suggests delivery before 37 weeks is a strong independent risk factor for IHD

Contact: Dana Kauffman,, 202-375-6294

WASHINGTON (Jun 29, 2020) -

Women who gave birth before their 37th week of pregnancy are at an increased risk of developing ischemic heart disease (IHD) over the course of their life independent of other risk factors such as BMI or smoking, according to a study published today in the Journal of the American College of Cardiology. The study findings suggest reproductive history should be routinely included in cardiovascular risk assessments of women.

Preterm delivery occurs in about 9.6% of births in the U.S. annually and is defined as any birth that occurs at less than 37 weeks. Women who deliver preterm have been found to have increased future risks of hypertension, diabetes and hyperlipidemia, which are huge risk factors for IHD. While previous studies have shown associations between preterm delivery and future risks of IHD, the long-term risks of IHD for women across their life course and how they vary by pregnancy duration has remained unclear. Furthermore, the relative contributions of shared familial (genetic and/or environmental) factors vs. direct effects of preterm delivery on the development of IHD have not been evaluated. This is the first study to assess the potential influence of unmeasured familial factors on associations between preterm delivery and future maternal risk of IHD.

Researchers used the Swedish Medical Birth Registry, which contains nearly all prenatal and birth information for deliveries in Sweden, to examine long-term changes in IHD risks in women who gave birth, with up to 43 years of follow-up, between 1973-2015. The researchers identified and studied 2,189,190 women who had singleton deliveries during the assessment period. Co-sibling analyses were performed among all 1,188,730 women (54.3%) with at least one sister who had a singleton delivery. The pregnancy duration observed included six groups: extremely preterm (22-27 weeks), very preterm (28-33 weeks), late preterm (34-36 weeks), early term (37-38 weeks), full-term (39-41 weeks, study’s reference group) and post-term (42 weeks or more). Additionally, the first three groups were combined to provide summary risk estimates for preterm delivery.

In 47.5 million person-years of follow-up, 49,955 (2.3%) women were diagnosed with IHD. In the 10 years following delivery, women who delivered preterm or extremely preterm had ~2.5- and four-fold risks of IHD, compared with those who delivered full-term, after adjusting for other maternal factors including preeclampsia, diabetes, high BMI and smoking. Early-term delivery also was associated with an increased risk of IHD (~1.4-fold). These risks subsequently declined but remained significantly elevated even 30-43 years after delivery. Results from the co-sibling analyses suggested that these findings were not attributable to shared genetic or environmental factors in families.

“Preterm delivery should now be recognized as an independent risk factor for IHD across the life course,” said Casey Crump, MD, PhD, a lead researcher of the study and professor of family medicine and community health at the Icahn School of Medicine at Mount Sinai in New York. “Cardiovascular risk assessment in women should routinely include reproductive history that covers preterm delivery and other pregnancy complications.  Women with a history of preterm delivery may warrant early preventive actions to reduce other IHD risk factors, including obesity, physical inactivity, and smoking, and long-term monitoring for timely detection and treatment of IHD.”

This study has several limitations, including the unavailability of detailed clinical data to verify IHD diagnoses; information on outpatient diagnoses wasn’t available until 2001, resulting in underreporting of IHD; and the possibility of incompletely controlled confounders such as maternal smoking, BMI or other IHD risk factors during pregnancy, which may have influenced results. Since this study was limited to Sweden, it will need replication in other countries, including racially diverse populations to explore for potential heterogeneity of findings.

“Associations between preterm birth and future CVD risk have been challenging to disentangle from potential confounders, such as genetics or behavioral and social factors, and one strength of this study is overcoming this limitation with inclusion of a co-sibling analysis,” said Anne Marie Valente, MD, Director of the Boston Adult Congenital Heart Program at Boston Children’s Hospital/Brigham and Women’s Hospital, in an accompanying editorial comment. “The higher IHD risk in women who had preterm birth persisted in co-sibling analysis, suggesting that shared genetic or environmental factors did not underlie the association with IHD. The novel results are a call to action for further development of the field of cardio-obstetrics.”

The American College of Cardiology envisions a world where innovation and knowledge optimize cardiovascular care and outcomes. As the professional home for the entire cardiovascular care team, the mission of the College and its 54,000 members is to transform cardiovascular care and to improve heart health. The ACC bestows credentials upon cardiovascular professionals who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. The College also provides professional medical education, disseminates cardiovascular research through its world-renowned JACC Journals, operates national registries to measure and improve care, and offers cardiovascular accreditation to hospitals and institutions. For more, visit

The Journal of the American College of Cardiology ranks among the top cardiovascular journals in the world for its scientific impact. JACC is the flagship for a family of journals—JACC: Cardiovascular Interventions, JACC: Cardiovascular Imaging, JACC: Heart Failure, JACC: Clinical Electrophysiology, JACC: Basic to Translational Science, JACC: Case Reports and JACC: CardioOncology—that prides themselves in publishing the top peer-reviewed research on all aspects of cardiovascular disease. Learn more at


< Back to Listings